section name header

Y-Site Injection Compatibility (1:1 Mixture)

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8, 1.2, and 2 mg/mLa)

C

Insulin

(Mfr: LI)(Conc: 1 unit/mLa)

Remarks:

Visually compatible for 4 hr at 20 to 24°C

Ref:

2928